[1]
|
Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer. https://gco.iarc.fr
|
[2]
|
Feng, R.M., Zong, Y.N., Cao, S.M., et al. (2019) Current Cancer Situation in China: Good or Bad News from the 2018 Global Cancer Statistics. Cancer Communications (London), 39, 1-12. https://doi.org/10.1186/s40880-019-0368-6
|
[3]
|
滕熠, 曹毛毛, 陈万青. 中国癌症筛查的发展、现状与挑战[J]. 中国肿瘤, 2022, 31(7): 481-487.
https://doi.org/10.11735/j.issn.1004-0242.2022.07.A001
|
[4]
|
World Health Organization (2022) Global Health Estimates: Leading Causes of Death.
https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death
|
[5]
|
de Koning, H.J., van der Aalst, C.M., de Jong, P.A., et al. (2020) Reduced Lung Cancer Mortality with Volume CT Screening in a Randomized Trial. The New England Journal of Medicine, 382, 503-513.
https://doi.org/10.1056/NEJMoa1911793
|
[6]
|
Aberle, D.R., Adams, A.M., Berg, C.D., et al. (2011) Reduced Lung Cancer Mortality with Low-Dose Computed Tomographic Screening. The New England Journal of Medicine, 365, 395-409. https://doi.org/10.1056/NEJMoa1102873
|
[7]
|
Li, N., Tan, F., Chen, W., et al. (2022) One-Off Low-Dose CT for Lung Cancer Screening in China: A Multicentre, Population Based, Prospective Cohort Study. The Lancet Respiratory Medicine, 10, 378-391.
https://doi.org/10.1016/S2213-2600(21)00560-9
|
[8]
|
中华预防医学会. 中国肺癌筛查标准(T/CPMA 013-2020) [J]. 中华肿瘤杂志, 2021, 43(1): 1-7.
|
[9]
|
Liu, M., He, Z., Guo, C., et al. (2019) Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based Study. American Journal of Epidemiology, 188, 776-784. https://doi.org/10.1093/aje/kwy291
|
[10]
|
赫捷, 陈万青, 李兆申, 等. 中国食管癌筛查与早诊早治指南(2022, 北京) [J]. 中国肿瘤, 2022, 31(6): 401-436.
|
[11]
|
Zhang, X., Li, M., Chen, S., et al. (2018) Endoscopic Screening in Asian Countries Is Associated with Reduced Gastric Cancer Mortality: A Meta-Analysis and Systematic Review. Gastroenterology, 155, 347-354.e9.
https://doi.org/10.1053/j.gastro.2018.04.026
|
[12]
|
李兆申, 王贵齐, 张澍田, 等. 中国早期胃癌筛查流程专家共识意见(草案) (2017年, 上海) [J]. 胃肠病学, 2018, 23(2): 92-97.
|
[13]
|
中华预防医学会肝胆胰疾病预防与控制专业委员会, 中国研究型医院学会肝病专业委员会, 中华医学会肝病学分会, 等原发性肝癌的分层筛查与监测指南(2020版) [J]. 中华肿瘤杂志, 2021, 43(1): 60-77.
|
[14]
|
Zhang, B.H., Yang, B.H. and Tang, Z.Y. (2004) Random-ized Controlled Trial of Screening for Hepatocellular Carcinoma. Journal of Clinical Oncology, 130, 417-422. https://doi.org/10.1007/s00432-004-0552-0
|
[15]
|
Simon, K. (2016) Colorectal Cancer Development and Advances in Screening. Clinical Interventions in Aging, 11, 967-976. https://doi.org/10.2147/CIA.S109285
|
[16]
|
Mariotto, A.B., Yabroff, F.R., Shao, Y., et al. (2011) Projections of the Cost of Cancer Case in the United States: 2010-2020. Journal of the National Cancer Institute, 103, 117-128. https://doi.org/10.1093/jnci/djq495
|
[17]
|
朱康, 周昌明, 郑莹. IARC对结直肠癌筛查方式评估的解读[J]. 上海预防医学, 2018, 30(9): 787-793.
|
[18]
|
陈万青, 李霓, 兰平, 等. 中国结直肠癌筛查与早诊早治指南(2020, 北京) [J]. 中国肿瘤, 2021, 30(1): 1-28.
|
[19]
|
ERNECV (2017) Breast Cancer Screening in Brazil. Barriers Related to the Health System. Revista da Associacao Medica Brasileira, 63, 446-474. https://doi.org/10.1590/1806-9282.63.05.466
|
[20]
|
Lee, C.S., Moy, L., Friedewald, S., et al. (2018) Harmonizing Breast Cancer Screening Recommendations: Metrics and Accountability. American Journal of Roentgenology, 210, 240-245. https://doi.org/10.2214/AJR.17.18704
|
[21]
|
Chinese Preventive Medicine Association and He, J. (2021) Female Breast Cancer Screening Guideline of China (T/CPMA 014-2020). Chinese Journal of Cancer Prevention and Treatment, 28, 9-18.
|